{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T03:57:06Z","timestamp":1771991826898,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiological Methods"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.mimet.2022.106480","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T12:30:35Z","timestamp":1651753835000},"page":"106480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Spectinomycin, gentamicin, and routine disc diffusion testing: An alternative for the treatment and monitoring of multidrug-resistant Neisseria gonorrhoeae?"],"prefix":"10.1016","volume":"197","author":[{"given":"J\u00e9ssica Motta","family":"Martins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara Cristina","family":"Scheffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanalydia","family":"de Melo Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Andr\u00e9","family":"Sch\u00f6rner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisl\u00e9ia","family":"Golfetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thais Mattos dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Hartmann","family":"Barazzetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Cavadas Barreto","family":"de Albuquerque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luiza","family":"Bazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mimet.2022.106480_bb0005","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/jac\/dkw102","article-title":"Gentamicin in vitro activity and tentative gentamicin interpretation criteria for the CLSI and calibrated dichotomous sensitivity disc diffusion methods for Neisseria gonorrhoeae","volume":"71","author":"Bala","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mimet.2022.106480_bb0010","first-page":"4","article-title":"First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015\u201316","author":"Bazzo","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mimet.2022.106480_bb0015","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1590\/S0365-05962002000600003","article-title":"Atividade in vitro de cinco drogas antimicrobianas contra Neisseria gonorrhoeae","volume":"77","author":"Belda Junior","year":"2002","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.mimet.2022.106480_bb0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1590\/S0036-46652007000100010","article-title":"Evaluation of the in vitro activity of six antimicrobial agents against Neisseria gonorrhoeae","volume":"49","author":"Belda Junior","year":"2007","journal-title":"Rev. Inst. Med. trop."},{"key":"10.1016\/j.mimet.2022.106480_bb0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0956462412472837","article-title":"European guideline on the diagnosis and treatment of gonorrhoeae in adults","volume":"24","author":"Bignell","year":"2013","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.mimet.2022.106480_bb0030","first-page":"1","article-title":"VITEK MS: Prep Station - user manual","volume":"1","author":"Biomerieux","year":"2011","journal-title":"Marcy l\u2019\u00c9toile, Fran\u00e7a"},{"key":"10.1016\/j.mimet.2022.106480_bb0035","first-page":"1","article-title":"VITEK MS: MALDI-TOF MS - User manual","volume":"3","author":"Biomerieux","year":"2016","journal-title":"Marcy l\u2019\u00c9toile, Fran\u00e7a"},{"key":"10.1016\/j.mimet.2022.106480_bb0040","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1056\/NEJM198707303170504","article-title":"Effect of spectinomycin use on the prevalence of spectinomycin-resistant and penicillinase-producing Neisseria gonorrhoeae","volume":"317","author":"Boslego","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mimet.2022.106480_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/OLQ.0b013e3181bf575c","article-title":"Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007","volume":"3","author":"Brown","year":"2010","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.mimet.2022.106480_bb0050","series-title":"Sexually Transmitted Diseases Treatment Guidelines","author":"CDC","year":"2015"},{"key":"10.1016\/j.mimet.2022.106480_bb0055","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1128\/AAC.00309-10","article-title":"High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes","volume":"54","author":"Chisholm","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2022.106480_bb0060","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jac\/dkq476","article-title":"An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe","volume":"66","author":"Chisholm","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mimet.2022.106480_bb0065","series-title":"Cumitech 31A, Verification and Validation of Procedures in the Clinical Microbiology Laboratory","author":"Clark","year":"2009"},{"key":"10.1016\/j.mimet.2022.106480_bb0070","series-title":"Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard - Twelfth Edition M02-A12","author":"Clinical and Laboratory Standards Institute","year":"2015"},{"key":"10.1016\/j.mimet.2022.106480_bb0075","series-title":"Development of in Vitro Susceptibility Testing Criteria and Quality Control Parameters M23Ed4","author":"Clinical and Laboratory Standards Institute","year":"2016"},{"key":"10.1016\/j.mimet.2022.106480_bb0080","series-title":"Performance Standards for Antimicrobial Susceptibility Testing M100-S31","author":"Clinical and Laboratory Standards Institute","year":"2021"},{"key":"10.1016\/j.mimet.2022.106480_bb0085","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1590\/0037-8682-0009-2013","article-title":"Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending a public referral center for sexually transmitted diseases in Belo Horizonte, State of Minas Gerais, Brazil","volume":"46","author":"Costa","year":"2013","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.mimet.2022.106480_bb0090","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1128\/jcm.35.11.2985-2988.1997","article-title":"Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: comparison of methods","volume":"35","author":"Daly","year":"1997","journal-title":"J. Clin. Microbiol."},{"issue":"28","key":"10.1016\/j.mimet.2022.106480_bb0095","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00007435-200109000-00008","article-title":"Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus Brazil, 1998","author":"Dillon","year":"2001","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.mimet.2022.106480_bb0100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/sextrans-2012-050905","article-title":"Two decades of the gonococcal antimicrobial surveillance program in South America and the Caribbean: challenges and opportunities","volume":"89","author":"Dillon","year":"2013","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.mimet.2022.106480_bb0105","first-page":"1","article-title":"Effectiveness of gentamicin for gonorrhoea treatment: systematic review and meta-analysis","volume":"0","author":"Dowell","year":"2012","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.mimet.2022.106480_bb0110","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1136\/bmj.289.6451.1032","article-title":"Spectinomycin as initial treatment for gonorrhoea","volume":"289","author":"Easman","year":"1984","journal-title":"Br. Med. J."},{"key":"10.1016\/j.mimet.2022.106480_bb0115","unstructured":"EUCAST. European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters. http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/Breakpoint_table_v_2.0_120221.pdf."},{"key":"10.1016\/j.mimet.2022.106480_bb0120","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMc1512757","article-title":"Failure of dual antimicrobial therapy in treatment of gonorrhoeae","volume":"374","author":"Fifer","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mimet.2022.106480_bb0125","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/OLQ.0b013e3181b61bb1","article-title":"Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina","volume":"36","author":"Galarza","year":"2009","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.mimet.2022.106480_bb0130","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3201\/eid2206.152091","article-title":"Neisseria gonorrhoeae resistant to ceftriaxone and cefixime, Argentina","volume":"22","author":"Gianecini","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.mimet.2022.106480_bb0135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.diagmicrobio.2018.03.005","article-title":"Comparison of disk diffusion and agar dilution methods for gentamicin susceptibility testing of Neisseria gonorrhoeae","volume":"91","author":"Gianecini","year":"2018","journal-title":"Diagnostic Microbiol. Infect. Dis."},{"key":"10.1016\/j.mimet.2022.106480_bb0140","author":"Global progress report on HIV"},{"key":"10.1016\/j.mimet.2022.106480_bb0145","first-page":"1","article-title":"315 antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential","author":"Lagac\u00e9-Wiens","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mimet.2022.106480_bb0150","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/jac\/dkv146","article-title":"Emergence of decreased susceptibility and resistance to extendedspectrum cephalosporins in Neisseria gonorrhoeae in Korea","volume":"70","author":"Lee","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mimet.2022.106480_bb0155","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/OLQ.0000000000000693","article-title":"Susceptibility of Neisseria gonorrhoeae to gentamicin-gonococcal isolate surveillance project, 2015-2016","volume":"45","author":"Mann","year":"2018","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.mimet.2022.106480_bb0160","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/jac\/dkn235","article-title":"Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland","volume":"62","author":"Palmer","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mimet.2022.106480_bb0165","series-title":"cl\u00ednico e diretrizes terap\u00eauticas para aten\u00e7\u00e3o integral \u00e0s pessoas com infec\u00e7\u00f5es sexualmente transmiss\u00edveis (IST)","author":"Protocolo","year":"2019"},{"key":"10.1016\/j.mimet.2022.106480_bb0170","first-page":"93","article-title":"The efficacy and safety of gentamicin for the treatment of genital, pharyngeal and rectal gonorrhoea: a randomised controlled trial","volume":"93","author":"Ross","year":"2017","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.mimet.2022.106480_bb0175","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/s41564-019-0501-y","article-title":"The impact of antimicrobials on gonococcal evolution","volume":"4","author":"Sanchez-Buso","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.mimet.2022.106480_bb0180","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/jac\/dkp118","article-title":"Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy","volume":"63","author":"Starnino","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mimet.2022.106480_bb0185","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/OLQ.0b013e3182631c9f","volume":"39","author":"Starnino","year":"2012","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.mimet.2022.106480_bb0190","first-page":"257","article-title":"Activity of eight antimicrobial agents in vitro against N. gonorrhoeae","author":"Stolz","year":"1975","journal-title":"Br. J. Vener. Dis"},{"key":"10.1016\/j.mimet.2022.106480_bb0195","series-title":"WHO (2017) Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics","first-page":"348","volume":"Vol. 43","author":"Tacconelli","year":"2013"},{"key":"10.1016\/j.mimet.2022.106480_bb0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/OLQ.0000000000000587","article-title":"Resistance to ceftriaxone and azithromycin in Neisseria gonorrhoeae isolates from 7 countries of South America and the Caribbean: 2010\u20132011","volume":"44","author":"Thakur","year":"2017","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.mimet.2022.106480_bb0205","first-page":"15","article-title":"Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge","volume":"364","author":"Unemo","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.mimet.2022.106480_bb0210","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.mimet.2022.106480_bb0215","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1128\/AAC.01775-12","article-title":"Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway","volume":"57","author":"Unemo","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2022.106480_bb0220","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1128\/microbiolspec.EI10-0009-2015","article-title":"Antimicrobial resistance expressed by Neisseria gonorrhoeae: a major global public health problem in the 21st century","volume":"4","author":"Unemo","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.mimet.2022.106480_bb0225","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1093\/jac\/dkw288","article-title":"The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization","volume":"71","author":"Unemo","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mimet.2022.106480_bb0230","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41572-019-0128-6","article-title":"Gonorr\u00e9ia","volume":"5","author":"Unemo","year":"2019","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.mimet.2022.106480_bb0235","first-page":"1","article-title":"Global antimicrobial resistance surveillance system","volume":"1","author":"WHO","year":"2015","journal-title":"World Heal. Organ."},{"key":"10.1016\/j.mimet.2022.106480_bb0240","first-page":"1","article-title":"WHO guidelines for the treatment of Neisseria gonorrhoeae","author":"WHO","year":"2016","journal-title":"World Heal. Organ."},{"key":"10.1016\/j.mimet.2022.106480_bb0245","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR"}],"container-title":["Journal of Microbiological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167701222000756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167701222000756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:04:37Z","timestamp":1759104277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167701222000756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":49,"alternative-id":["S0167701222000756"],"URL":"https:\/\/doi.org\/10.1016\/j.mimet.2022.106480","relation":{},"ISSN":["0167-7012"],"issn-type":[{"value":"0167-7012","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spectinomycin, gentamicin, and routine disc diffusion testing: An alternative for the treatment and monitoring of multidrug-resistant Neisseria gonorrhoeae?","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mimet.2022.106480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106480"}}